Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 5Gastrointestinal 3Gynecologic 2Genitourinary 2Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Muscle Weakness 1

Interventions

venetoclax 73Specimen Handling 66Cyclophosphamide 58Cytarabine 50Biopsy 49fludarabine 42Azacitidine 37Rituximab 28fludarabine phosphate 21blinatumomab 20Methotrexate 20Magnetic Resonance Spectroscopy 20Daunorubicin 20Vincristine 19Prednisone 18ibrutinib 16Injections 16Dexamethasone 16decitabine and cedazuridine drug combination 15Whole-Body Irradiation 15Tacrolimus 14Melphalan 14Doxorubicin 14Busulfan 14obinutuzumab 13acalabrutinib 13Mycophenolic Acid 13Granulocyte Colony-Stimulating Factor 13merphos 12Mercaptopurine 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Magnetic Resonance Imaging × Other hematologic neoplasm × 30 days × Clear all
NCT06819475 2026-05-18

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

St. Jude Children's Research Hospital

Phase NA Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasms, Muscle Weakness, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡